Literature DB >> 25740092

Prostate cancer: active surveillance may prove organisationally impossible.

W P Tormey1.   

Abstract

Entities:  

Year:  2015        PMID： 25740092     DOI： 10.1007/s11845-015-1274-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  14 in total

1.  Calling time on the 10-minute consultation.

Authors:  Greg Irving; John Holden
Journal:  Br J Gen Pract       Date:  2012-05       Impact factor: 5.386

Review 2.  The Melbourne Consensus Statement on the early detection of prostate cancer.

Authors:  Declan G Murphy; Thomas Ahlering; William J Catalona; Helen Crowe; Jane Crowe; Noel Clarke; Matthew Cooperberg; David Gillatt; Martin Gleave; Stacy Loeb; Monique Roobol; Oliver Sartor; Tom Pickles; Addie Wootten; Patrick C Walsh; Anthony J Costello
Journal:  BJU Int       Date:  2014-02       Impact factor: 5.588

3.  Active surveillance for low-risk prostate cancer: diversity of practice across Europe.

Authors:  A Azmi; R A Dillon; S Borghesi; M Dunne; R E Power; L Marignol; B D P O'Neill
Journal:  Ir J Med Sci       Date:  2014-03-21       Impact factor: 1.568

4.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

5.  A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland.

Authors:  J C Forde; P J Daly; S White; M Morrin; G P Smyth; B D P O'Neill; R E Power
Journal:  Ir J Med Sci       Date:  2013-09-29       Impact factor: 1.568

6.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

Review 7.  Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review.

Authors:  Ivo G Schoots; Neophytos Petrides; Francesco Giganti; Leonard P Bokhorst; Antti Rannikko; Laurence Klotz; Arnauld Villers; Jonas Hugosson; Caroline M Moore
Journal:  Eur Urol       Date:  2014-11-15       Impact factor: 20.096

8.  Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.

Authors:  Anurag K Singh; Jochen Kruecker; Sheng Xu; Neil Glossop; Peter Guion; Karen Ullman; Peter L Choyke; Bradford J Wood
Journal:  BJU Int       Date:  2007-12-05       Impact factor: 5.588

9.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

10.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.